Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test.
作者信息
Waterboer Tim, Brenner Nicole, Klussmann Jens P, Brennan Paul, Wieland Ulrike, Robbins Hilary A
机构信息
Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Infections and Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
出版信息
EBioMedicine. 2020 Dec;62:103143. doi: 10.1016/j.ebiom.2020.103143. Epub 2020 Nov 27.
Abstract
摘要
相似文献
1
Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test.研究结果及相关证据不支持将人乳头瘤病毒16型L1 DRH1抗体用作癌症筛查检测。
EBioMedicine. 2020 Dec;62:103143. doi: 10.1016/j.ebiom.2020.103143. Epub 2020 Nov 27.
2
DRH1 - a novel blood-based HPV tumour marker.DRH1-一种新型基于血液的 HPV 肿瘤标志物。
EBioMedicine. 2020 Jun;56:102804. doi: 10.1016/j.ebiom.2020.102804. Epub 2020 Jun 11.
3
Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.人乳头瘤病毒16型（HPV16）L2的血清流行病学及L2特异性人嵌合单克隆抗体的产生
Clin Vaccine Immunol. 2015 Jul;22(7):806-16. doi: 10.1128/CVI.00799-14. Epub 2015 May 13.
4
Association of antibody to E2 protein of human papillomavirus and p16 with progression of HPV-infected cervical lesions.人乳头瘤病毒 E2 蛋白抗体和 p16 与 HPV 感染宫颈病变进展的关系。
Med Oncol. 2018 May 9;35(6):93. doi: 10.1007/s12032-018-1151-2.
5
A novel fluorescence immunoassay for the quantitative detection of HPV16 L1 antibodies in human serum samples using ZnCdSe/ZnS quantum dot-labeled antibodies.一种使用ZnCdSe/ZnS量子点标记抗体定量检测人血清样本中HPV16 L1抗体的新型荧光免疫分析方法。
Microbiol Spectr. 2025 May 6;13(5):e0184324. doi: 10.1128/spectrum.01843-24. Epub 2025 Apr 8.
6
[Production of human papillomavirus type 16 virus-like particles and its immunogenicity].[人乳头瘤病毒16型病毒样颗粒的制备及其免疫原性]
Bing Du Xue Bao. 2009 Jul;25(4):245-50.
7
Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.HPV 病毒 DNA 检测与 HPV16 型病毒衣壳蛋白 L1 加 L2 型病毒衣壳蛋白检测的血清学反应之间的相关性。
J Med Microbiol. 2020 Jul;69(7):960-970. doi: 10.1099/jmm.0.001213.
8
Prevalence of HPV-DNA and anti-HPV antibodies in women from Girardot, Colombia.哥伦比亚吉拉尔多市女性中HPV-DNA和抗HPV抗体的流行情况。
Sex Transm Dis. 2009 May;36(5):290-6. doi: 10.1097/OLQ.0b013e318195762c.
9
Clinicopathological implications of human papilloma virus (HPV) L1 capsid protein immunoreactivity in HPV16-positive cervical cytology.HPV16 阳性宫颈细胞学中人乳头瘤病毒（HPV）L1 衣壳蛋白免疫反应的临床病理意义。
Int J Med Sci. 2013 Dec 20;11(1):80-6. doi: 10.7150/ijms.5585. eCollection 2014.
10
Response to: "Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test".对“研究结果及相关证据不支持将HPV16 L1 DRH1抗体用作癌症筛查检测”的回应。
EBioMedicine. 2020 Dec;62:103139. doi: 10.1016/j.ebiom.2020.103139. Epub 2020 Nov 27.
引用本文的文献
1
Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma.口咽癌和下咽癌基于证据的诊断、治疗、预防及术后护理指南
Ger Med Sci. 2025 Jun 24;23:Doc03. doi: 10.3205/000339. eCollection 2025.
2
[Epidemiology and prevention of oropharyngeal cancer : Summary of the new German S3 guideline].[口咽癌的流行病学与预防：德国新S3指南总结]
HNO. 2025 Mar;73(3):213-224. doi: 10.1007/s00106-025-01552-0.
3
High levels of HPV16-L1 antibody but not HPV16 DNA load or integration predict oropharyngeal patient outcome: The Papillophar study.高水平的人乳头瘤病毒16型L1抗体而非人乳头瘤病毒16型DNA载量或整合情况可预测口咽癌患者的预后：乳头瘤病毒与口咽癌研究。
Clin Exp Med. 2023 Feb;23(1):87-96. doi: 10.1007/s10238-022-00796-2. Epub 2022 Feb 23.
Zotero 插件